vimarsana.com

மருந்துகள் சீராக்கி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Medicines regulator appeals to Treasury for more funding

Medicines regulator appeals to Treasury for more funding Most Read Most Read Most Read Most Read Most Read Most Read Most Read Most Read Medicines regulator appeals to Treasury for more funding After a cut in Treasury allocation of 8%, authority tells MPs that understaffing affects the speed and efficacy with which it can make regulatory decisions BL PREMIUM 05 May 2021 - 19:43 Tamar Kahn The medicines regulator has appealed to the Treasury for a bigger budget, warning that it cannot do its job effectively unless key vacancies are filled. The SA Health Products Regulatory Authority (Sahpra) shot to public prominence during the coronavirus pandemic as it plays a pivotal role in approving new diagnostics, vaccines and treatments. It is one of the most stringent medicine regulators on the African continent and responsible for overseeing the safety and efficacy of human and animal medicines, medical devices and clinical trials.

Pfizer Withdraws Emergency-Use Application for its COVID-19 Vaccine in India

Pfizer Withdraws Emergency-Use Application for its COVID-19 Vaccine in India The Central Drugs Standard Control Organisation had earlier declined to approve Pfizer s vaccine without a small local trial on its safety and immunogenicity for Indians. Syringes seen in front of BioNTech and Pfizer logos. Photo: Reuters/Dado Ruvic/File Photo. Health05/Feb/2021 New Delhi: Pfizer Inc has withdrawn an application for emergency-use authorisation of its COVID-19 vaccine in India that it has developed with Germany’s BioNTech, the company told Reuters on Friday. The US company, which was the first drugmaker to apply for emergency use authorisation of its COVID-19 vaccine in India, had a meeting with the Central Drugs Standard Control Organisation on Wednesday and the decision was made after that, the company said.

Preview Page - Biosimilars – a 2020 perspective for Ireland

Preview Page - Biosimilars – a 2020 perspective for Ireland
imt.ie - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from imt.ie Daily Mail and Mail on Sunday newspapers.

V G Somani: The DCGI chief, a man known by his actions, not of words

Exclusive content, features, opinions and comment - hand-picked by our editors, just for you. Pick 5 of your favourite companies. Get a daily email with all the news updates on them. Track the industry of your choice with a daily newsletter specific to that industry. Stay on top of your investments. Track stock prices in your portfolio. NOTE : This product is a monthly auto renewal product. Cancellation Policy: You can cancel any time in the future without assigning any reasons, but 48 hours prior to your card being charged for renewal. We do not offer any refunds. To cancel, communicate from your registered email id and send the mail with the request to assist@bsmail.in. Include your contact number for easy reference. Requests mailed to any other ID will not be acknowledged or actioned upon.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.